Literature DB >> 25036057

Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.

Isabelle Runkle, Carles Villabona, Andrés Navarro, Antonio Pose, Francesc Formiga, Alberto Tejedor, Esteban Poch.   

Abstract

INTRODUCTION: The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most frequent cause of hyponatremia in a hospital setting. However, detailed protocols and algorithms for its management are lacking. Our objective was to develop 2 consensus algorithms for the therapy of hyponatremia due to SIADH in hospitalized patients.
MATERIAL AND METHODS: A multidisciplinary group made up of 2 endocrinologists, 2 nephrologists, 2 internists, and one hospital pharmacist held meetings over the period of a year. The group worked under the auspices of the European Hyponatremia Network and the corresponding Spanish medical societies. Therapeutic proposals were based on widely-accepted recommendations, expert opinion and consensus guidelines, as well as on the authors’ personal experience.
RESULTS: Two algorithms were developed. Algorithm 1 addresses acute correction of hyponatremia posing as a medical emergency, and is applicable to both severe euvolemic and hypovolemic hyponatremia. The mainstay of this algorithm is the iv use of 3% hypertonic saline solution. Specific infusion rates are proposed, as are steps to avoid or reverse overcorrection of serum sodium levels. Algorithm 2 is directed to the therapy of SIADH-induced mild or moderate, non-acute hyponatremia. It addresses when and how to use fluid restriction, solute, furosemide, and tolvaptan to achieve eunatremia in patients with SIADH.
CONCLUSIONS: Two complementary strategies were elaborated to treat SIADH-induced hyponatremia in an attempt to increase awareness of its importance, simplify its therapy, and improve prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036057     DOI: 10.3265/Nefrologia.pre2014.Apr.12220

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  5 in total

1.  Syringomyelia associated with inappropriate antidiuretic hormone secretion.

Authors:  Paula Barros Alcalde; Arturo González Quintela; Marta Pena Seijo; Antonio Pose-Reino
Journal:  BMJ Case Rep       Date:  2014-04-11

2.  Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.

Authors:  Antonio Pose; Luis Almenar; Juan José Gavira; Amador López-Granados; Teresa Blasco; Juan Delgado; Oscar Aramburu; Avelino Rodríguez; Luis Manzano; Nicolás Manito
Journal:  ESC Heart Fail       Date:  2017-01-19

3.  Acute Severe Hypovolemic Hyponatremia in a Patient on Intravenous Dexamethasone.

Authors:  Sameer Peer; Dinesh A Sharma; Chandrajit Prasad; Karthik K
Journal:  Cureus       Date:  2022-03-11

Review 4.  Managing hyponatremia in lung cancer: latest evidence and clinical implications.

Authors:  Ilaria Fiordoliva; Tania Meletani; Maria Giuditta Baleani; Silvia Rinaldi; Agnese Savini; Marzia Di Pietro Paolo; Rossana Berardi
Journal:  Ther Adv Med Oncol       Date:  2017-10-28       Impact factor: 8.168

5.  The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases.

Authors:  Peng Ren; Qiuan Yang
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.